A randomised controlled trial of vitamin D and omega-3 long chain polyunsaturated fatty acids in the treatment of irritability and hyperactivity among children with autism spectrum disorder

Related Studies

Mineral-vitamin treatment associated with remission in attention-deficit/hyperactivity disorder symptoms and related problems: 1-year naturalistic outcomes of a 10-week randomized placebo-controlled trial

This 2019 article presents the findings of a randomized trial that analyzed the efficacy of a broad-spectrum micronutrient intervention on several psychological outcomes in children with attention deficit hyperactivity disorder (ADHD). The paper aimed to show the effects of the intervention at the 1-year follow-up. Researchers measured the kids’ general function and signs of ADHD, […]

Impact of polyunsaturated fatty acids on patient-important outcomes in children and adolescents with autism spectrum disorder: a systematic review

Since international guidelines have not yet considered the available evidence showing the efficacy of polyunsaturated fatty acids (PUFAs) in autism spectrum disorder (ASD), this 2020 article aims to examine the effectiveness of PUFAs in children and adolescents with ASD for the Italian national guidelines on the management of ASD in children and adolescents. A systematic […]